Allied Healthcare Products, Inc.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ABT has a market cap of 232.03B. Regarding current trading prices, AHPI is priced at $0.00, while ABT trades at $133.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ABT's P/E ratio is 17.32. In terms of profitability, AHPI's ROE is -0.68%, compared to ABT's ROE of +0.24%. Regarding short-term risk, AHPI is less volatile compared to ABT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BSX-PA has a market cap of 175.45B. Regarding current trading prices, AHPI is priced at $0.00, while BSX-PA trades at $122.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, AHPI's ROE is -0.68%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, AHPI is less volatile compared to BSX-PA. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BSX has a market cap of 155.14B. Regarding current trading prices, AHPI is priced at $0.00, while BSX trades at $104.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BSX's P/E ratio is 76.54. In terms of profitability, AHPI's ROE is -0.68%, compared to BSX's ROE of +0.10%. Regarding short-term risk, AHPI is less volatile compared to BSX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SYK has a market cap of 149.89B. Regarding current trading prices, AHPI is priced at $0.00, while SYK trades at $392.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SYK's P/E ratio is 52.86. In terms of profitability, AHPI's ROE is -0.68%, compared to SYK's ROE of +0.11%. Regarding short-term risk, AHPI is less volatile compared to SYK. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, MDT has a market cap of 110.44B. Regarding current trading prices, AHPI is priced at $0.00, while MDT trades at $86.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas MDT's P/E ratio is 26.25. In terms of profitability, AHPI's ROE is -0.68%, compared to MDT's ROE of +0.09%. Regarding short-term risk, AHPI is less volatile compared to MDT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, EW has a market cap of 45.09B. Regarding current trading prices, AHPI is priced at $0.00, while EW trades at $76.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas EW's P/E ratio is 31.76. In terms of profitability, AHPI's ROE is -0.68%, compared to EW's ROE of +0.49%. Regarding short-term risk, AHPI is less volatile compared to EW. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, DXCM has a market cap of 33.59B. Regarding current trading prices, AHPI is priced at $0.00, while DXCM trades at $85.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas DXCM's P/E ratio is 64.41. In terms of profitability, AHPI's ROE is -0.68%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, AHPI is less volatile compared to DXCM. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, STE has a market cap of 24.25B. Regarding current trading prices, AHPI is priced at $0.00, while STE trades at $246.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas STE's P/E ratio is 39.74. In terms of profitability, AHPI's ROE is -0.68%, compared to STE's ROE of +0.07%. Regarding short-term risk, AHPI is less volatile compared to STE. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, PODD has a market cap of 22.66B. Regarding current trading prices, AHPI is priced at $0.00, while PODD trades at $322.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas PODD's P/E ratio is 57.92. In terms of profitability, AHPI's ROE is -0.68%, compared to PODD's ROE of +0.35%. Regarding short-term risk, AHPI is less volatile compared to PODD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, PHG has a market cap of 22.46B. Regarding current trading prices, AHPI is priced at $0.00, while PHG trades at $24.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas PHG's P/E ratio is 83.72. In terms of profitability, AHPI's ROE is -0.68%, compared to PHG's ROE of -0.06%. Regarding short-term risk, AHPI is less volatile compared to PHG. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ZBH has a market cap of 19.13B. Regarding current trading prices, AHPI is priced at $0.00, while ZBH trades at $96.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ZBH's P/E ratio is 21.48. In terms of profitability, AHPI's ROE is -0.68%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, AHPI is less volatile compared to ZBH. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ABMD has a market cap of 17.18B. Regarding current trading prices, AHPI is priced at $0.00, while ABMD trades at $381.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ABMD's P/E ratio is 65.36. In terms of profitability, AHPI's ROE is -0.68%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, AHPI is less volatile compared to ABMD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ALGN has a market cap of 13.53B. Regarding current trading prices, AHPI is priced at $0.00, while ALGN trades at $186.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ALGN's P/E ratio is 33.95. In terms of profitability, AHPI's ROE is -0.68%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, AHPI is less volatile compared to ALGN. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SNN has a market cap of 12.59B. Regarding current trading prices, AHPI is priced at $0.00, while SNN trades at $28.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SNN's P/E ratio is 30.61. In terms of profitability, AHPI's ROE is -0.68%, compared to SNN's ROE of +0.08%. Regarding short-term risk, AHPI is less volatile compared to SNN. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SWAV has a market cap of 12.57B. Regarding current trading prices, AHPI is priced at $0.00, while SWAV trades at $334.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SWAV's P/E ratio is 78.76. In terms of profitability, AHPI's ROE is -0.68%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, AHPI is less volatile compared to SWAV. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, PEN has a market cap of 10.65B. Regarding current trading prices, AHPI is priced at $0.00, while PEN trades at $275.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas PEN's P/E ratio is 257.07. In terms of profitability, AHPI's ROE is -0.68%, compared to PEN's ROE of +0.04%. Regarding short-term risk, AHPI is less volatile compared to PEN. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, GMED has a market cap of 7.83B. Regarding current trading prices, AHPI is priced at $0.00, while GMED trades at $57.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas GMED's P/E ratio is 43.15. In terms of profitability, AHPI's ROE is -0.68%, compared to GMED's ROE of +0.05%. Regarding short-term risk, AHPI is less volatile compared to GMED. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BIO-B has a market cap of 6.87B. Regarding current trading prices, AHPI is priced at $0.00, while BIO-B trades at $250.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BIO-B's P/E ratio is -3.27. In terms of profitability, AHPI's ROE is -0.68%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, AHPI and BIO-B have similar daily volatility (0.00).

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BIO has a market cap of 6.64B. Regarding current trading prices, AHPI is priced at $0.00, while BIO trades at $243.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BIO's P/E ratio is -3.18. In terms of profitability, AHPI's ROE is -0.68%, compared to BIO's ROE of -0.32%. Regarding short-term risk, AHPI is less volatile compared to BIO. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BRKR has a market cap of 5.56B. Regarding current trading prices, AHPI is priced at $0.00, while BRKR trades at $36.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BRKR's P/E ratio is 70.56. In terms of profitability, AHPI's ROE is -0.68%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, AHPI is less volatile compared to BRKR. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, GKOS has a market cap of 5.24B. Regarding current trading prices, AHPI is priced at $0.00, while GKOS trades at $91.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas GKOS's P/E ratio is -40.39. In terms of profitability, AHPI's ROE is -0.68%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, AHPI is less volatile compared to GKOS. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, NARI has a market cap of 4.68B. Regarding current trading prices, AHPI is priced at $0.00, while NARI trades at $79.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas NARI's P/E ratio is -59.24. In terms of profitability, AHPI's ROE is -0.68%, compared to NARI's ROE of -0.18%. Regarding short-term risk, AHPI is less volatile compared to NARI. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, IRTC has a market cap of 4.50B. Regarding current trading prices, AHPI is priced at $0.00, while IRTC trades at $141.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas IRTC's P/E ratio is -45.06. In terms of profitability, AHPI's ROE is -0.68%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, AHPI is less volatile compared to IRTC. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, INSP has a market cap of 4.41B. Regarding current trading prices, AHPI is priced at $0.00, while INSP trades at $149.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas INSP's P/E ratio is 70.24. In terms of profitability, AHPI's ROE is -0.68%, compared to INSP's ROE of +0.10%. Regarding short-term risk, AHPI is less volatile compared to INSP. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ITGR has a market cap of 4.15B. Regarding current trading prices, AHPI is priced at $0.00, while ITGR trades at $119.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ITGR's P/E ratio is 55.35. In terms of profitability, AHPI's ROE is -0.68%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, AHPI is less volatile compared to ITGR. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, TMDX has a market cap of 4.12B. Regarding current trading prices, AHPI is priced at $0.00, while TMDX trades at $121.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas TMDX's P/E ratio is 85.78. In terms of profitability, AHPI's ROE is -0.68%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, AHPI is less volatile compared to TMDX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, AXNX has a market cap of 3.63B. Regarding current trading prices, AHPI is priced at $0.00, while AXNX trades at $70.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas AXNX's P/E ratio is -709.80. In terms of profitability, AHPI's ROE is -0.68%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, AHPI and AXNX have similar daily volatility (0.00).

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, PRCT has a market cap of 3.22B. Regarding current trading prices, AHPI is priced at $0.00, while PRCT trades at $58.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas PRCT's P/E ratio is -34.38. In terms of profitability, AHPI's ROE is -0.68%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, AHPI is less volatile compared to PRCT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, LIVN has a market cap of 2.39B. Regarding current trading prices, AHPI is priced at $0.00, while LIVN trades at $43.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas LIVN's P/E ratio is -10.77. In terms of profitability, AHPI's ROE is -0.68%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, AHPI is less volatile compared to LIVN. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, NUVA has a market cap of 2.08B. Regarding current trading prices, AHPI is priced at $0.00, while NUVA trades at $39.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas NUVA's P/E ratio is 75.00. In terms of profitability, AHPI's ROE is -0.68%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, AHPI is less volatile compared to NUVA. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, UFPT has a market cap of 1.88B. Regarding current trading prices, AHPI is priced at $0.00, while UFPT trades at $243.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas UFPT's P/E ratio is 29.90. In terms of profitability, AHPI's ROE is -0.68%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, AHPI is less volatile compared to UFPT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ATEC has a market cap of 1.86B. Regarding current trading prices, AHPI is priced at $0.00, while ATEC trades at $12.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ATEC's P/E ratio is -11.18. In terms of profitability, AHPI's ROE is -0.68%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, AHPI is less volatile compared to ATEC. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CNMD has a market cap of 1.85B. Regarding current trading prices, AHPI is priced at $0.00, while CNMD trades at $59.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CNMD's P/E ratio is 16.04. In terms of profitability, AHPI's ROE is -0.68%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, AHPI is less volatile compared to CNMD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, TNDM has a market cap of 1.51B. Regarding current trading prices, AHPI is priced at $0.00, while TNDM trades at $22.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas TNDM's P/E ratio is -8.14. In terms of profitability, AHPI's ROE is -0.68%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, AHPI is less volatile compared to TNDM. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, HSKA has a market cap of 1.31B. Regarding current trading prices, AHPI is priced at $0.00, while HSKA trades at $119.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas HSKA's P/E ratio is -62.49. In terms of profitability, AHPI's ROE is -0.68%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, AHPI and HSKA have similar daily volatility (0.00).

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, AORT has a market cap of 1.24B. Regarding current trading prices, AHPI is priced at $0.00, while AORT trades at $28.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas AORT's P/E ratio is -56.80. In terms of profitability, AHPI's ROE is -0.68%, compared to AORT's ROE of -0.07%. Regarding short-term risk, AHPI is less volatile compared to AORT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, AHCO has a market cap of 1.22B. Regarding current trading prices, AHPI is priced at $0.00, while AHCO trades at $9.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas AHCO's P/E ratio is 15.59. In terms of profitability, AHPI's ROE is -0.68%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, AHPI is less volatile compared to AHCO. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SILK has a market cap of 1.12B. Regarding current trading prices, AHPI is priced at $0.00, while SILK trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SILK's P/E ratio is -18.96. In terms of profitability, AHPI's ROE is -0.68%, compared to SILK's ROE of -0.37%. Regarding short-term risk, AHPI is less volatile compared to SILK. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, FNA has a market cap of 1.10B. Regarding current trading prices, AHPI is priced at $0.00, while FNA trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas FNA's P/E ratio is -19.83. In terms of profitability, AHPI's ROE is -0.68%, compared to FNA's ROE of -0.36%. Regarding short-term risk, AHPI is less volatile compared to FNA. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ESTA has a market cap of 1.06B. Regarding current trading prices, AHPI is priced at $0.00, while ESTA trades at $36.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ESTA's P/E ratio is -11.27. In terms of profitability, AHPI's ROE is -0.68%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, AHPI is less volatile compared to ESTA. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, INMD has a market cap of 1.02B. Regarding current trading prices, AHPI is priced at $0.00, while INMD trades at $14.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas INMD's P/E ratio is 6.60. In terms of profitability, AHPI's ROE is -0.68%, compared to INMD's ROE of +0.25%. Regarding short-term risk, AHPI is less volatile compared to INMD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, IART has a market cap of 1.01B. Regarding current trading prices, AHPI is priced at $0.00, while IART trades at $13.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas IART's P/E ratio is -34.24. In terms of profitability, AHPI's ROE is -0.68%, compared to IART's ROE of -0.03%. Regarding short-term risk, AHPI is less volatile compared to IART. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CSII has a market cap of 843.96M. Regarding current trading prices, AHPI is priced at $0.00, while CSII trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CSII's P/E ratio is -20.83. In terms of profitability, AHPI's ROE is -0.68%, compared to CSII's ROE of -0.14%. Regarding short-term risk, AHPI is less volatile compared to CSII. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CRY has a market cap of 725.15M. Regarding current trading prices, AHPI is priced at $0.00, while CRY trades at $17.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CRY's P/E ratio is 425.71. In terms of profitability, AHPI's ROE is -0.68%, compared to CRY's ROE of -0.07%. Regarding short-term risk, AHPI is less volatile compared to CRY. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SIBN has a market cap of 719.58M. Regarding current trading prices, AHPI is priced at $0.00, while SIBN trades at $16.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SIBN's P/E ratio is -22.60. In terms of profitability, AHPI's ROE is -0.68%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, AHPI is less volatile compared to SIBN. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, IRMD has a market cap of 684.84M. Regarding current trading prices, AHPI is priced at $0.00, while IRMD trades at $53.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas IRMD's P/E ratio is 34.75. In terms of profitability, AHPI's ROE is -0.68%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, AHPI is less volatile compared to IRMD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CBLL has a market cap of 635.76M. Regarding current trading prices, AHPI is priced at $0.00, while CBLL trades at $17.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CBLL's P/E ratio is -14.07. In terms of profitability, AHPI's ROE is -0.68%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, AHPI is less volatile compared to CBLL. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, AVNS has a market cap of 589.61M. Regarding current trading prices, AHPI is priced at $0.00, while AVNS trades at $12.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas AVNS's P/E ratio is -1.54. In terms of profitability, AHPI's ROE is -0.68%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, AHPI is less volatile compared to AVNS. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, APEN has a market cap of 579.72M. Regarding current trading prices, AHPI is priced at $0.00, while APEN trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas APEN's P/E ratio is -9.43. In terms of profitability, AHPI's ROE is -0.68%, compared to APEN's ROE of -0.85%. Regarding short-term risk, AHPI is less volatile compared to APEN. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BFLY has a market cap of 567.53M. Regarding current trading prices, AHPI is priced at $0.00, while BFLY trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BFLY's P/E ratio is -7.65. In terms of profitability, AHPI's ROE is -0.68%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, AHPI is less volatile compared to BFLY. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, KIDS has a market cap of 566.47M. Regarding current trading prices, AHPI is priced at $0.00, while KIDS trades at $22.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas KIDS's P/E ratio is -12.99. In terms of profitability, AHPI's ROE is -0.68%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, AHPI is less volatile compared to KIDS. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, NPCE has a market cap of 560.20M. Regarding current trading prices, AHPI is priced at $0.00, while NPCE trades at $17.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas NPCE's P/E ratio is -18.37. In terms of profitability, AHPI's ROE is -0.68%, compared to NPCE's ROE of -2.58%. Regarding short-term risk, AHPI is less volatile compared to NPCE. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BFLY-WT has a market cap of 550.71M. Regarding current trading prices, AHPI is priced at $0.00, while BFLY-WT trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, AHPI's ROE is -0.68%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, AHPI is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, RXST has a market cap of 540.88M. Regarding current trading prices, AHPI is priced at $0.00, while RXST trades at $13.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas RXST's P/E ratio is -20.17. In terms of profitability, AHPI's ROE is -0.68%, compared to RXST's ROE of -0.10%. Regarding short-term risk, AHPI is less volatile compared to RXST. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, AXGN has a market cap of 536.51M. Regarding current trading prices, AHPI is priced at $0.00, while AXGN trades at $11.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas AXGN's P/E ratio is -73.62. In terms of profitability, AHPI's ROE is -0.68%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, AHPI is less volatile compared to AXGN. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, OFIX has a market cap of 478.01M. Regarding current trading prices, AHPI is priced at $0.00, while OFIX trades at $12.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas OFIX's P/E ratio is -3.30. In terms of profitability, AHPI's ROE is -0.68%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, AHPI is less volatile compared to OFIX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BVS has a market cap of 433.98M. Regarding current trading prices, AHPI is priced at $0.00, while BVS trades at $6.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BVS's P/E ratio is -13.91. In terms of profitability, AHPI's ROE is -0.68%, compared to BVS's ROE of -0.21%. Regarding short-term risk, AHPI is less volatile compared to BVS. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, TMCI has a market cap of 424.61M. Regarding current trading prices, AHPI is priced at $0.00, while TMCI trades at $6.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas TMCI's P/E ratio is -7.94. In terms of profitability, AHPI's ROE is -0.68%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, AHPI is less volatile compared to TMCI. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SRDX has a market cap of 400.81M. Regarding current trading prices, AHPI is priced at $0.00, while SRDX trades at $28.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SRDX's P/E ratio is -20.02. In terms of profitability, AHPI's ROE is -0.68%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, AHPI is less volatile compared to SRDX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CLPT has a market cap of 365.18M. Regarding current trading prices, AHPI is priced at $0.00, while CLPT trades at $12.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CLPT's P/E ratio is -18.46. In terms of profitability, AHPI's ROE is -0.68%, compared to CLPT's ROE of -0.62%. Regarding short-term risk, AHPI is less volatile compared to CLPT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SENS has a market cap of 356.65M. Regarding current trading prices, AHPI is priced at $0.00, while SENS trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SENS's P/E ratio is -4.96. In terms of profitability, AHPI's ROE is -0.68%, compared to SENS's ROE of -7.46%. Regarding short-term risk, AHPI is less volatile compared to SENS. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, NNOX has a market cap of 347.50M. Regarding current trading prices, AHPI is priced at $0.00, while NNOX trades at $5.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas NNOX's P/E ratio is -5.99. In terms of profitability, AHPI's ROE is -0.68%, compared to NNOX's ROE of -0.30%. Regarding short-term risk, AHPI is less volatile compared to NNOX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, OM has a market cap of 346.47M. Regarding current trading prices, AHPI is priced at $0.00, while OM trades at $19.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas OM's P/E ratio is -0.68. In terms of profitability, AHPI's ROE is -0.68%, compared to OM's ROE of -1.45%. Regarding short-term risk, AHPI is less volatile compared to OM. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CTKB has a market cap of 339.45M. Regarding current trading prices, AHPI is priced at $0.00, while CTKB trades at $2.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CTKB's P/E ratio is -29.78. In terms of profitability, AHPI's ROE is -0.68%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, AHPI is less volatile compared to CTKB. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, VREX has a market cap of 327.44M. Regarding current trading prices, AHPI is priced at $0.00, while VREX trades at $7.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas VREX's P/E ratio is -7.66. In terms of profitability, AHPI's ROE is -0.68%, compared to VREX's ROE of -0.08%. Regarding short-term risk, AHPI is less volatile compared to VREX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, PACB has a market cap of 318.09M. Regarding current trading prices, AHPI is priced at $0.00, while PACB trades at $1.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas PACB's P/E ratio is -0.39. In terms of profitability, AHPI's ROE is -0.68%, compared to PACB's ROE of -1.25%. Regarding short-term risk, AHPI is less volatile compared to PACB. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SMLR has a market cap of 312.27M. Regarding current trading prices, AHPI is priced at $0.00, while SMLR trades at $32.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SMLR's P/E ratio is 6.34. In terms of profitability, AHPI's ROE is -0.68%, compared to SMLR's ROE of +0.35%. Regarding short-term risk, AHPI is less volatile compared to SMLR. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, VMD has a market cap of 266.39M. Regarding current trading prices, AHPI is priced at $0.00, while VMD trades at $6.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas VMD's P/E ratio is 22.47. In terms of profitability, AHPI's ROE is -0.68%, compared to VMD's ROE of +0.10%. Regarding short-term risk, AHPI is less volatile compared to VMD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CERS has a market cap of 246.60M. Regarding current trading prices, AHPI is priced at $0.00, while CERS trades at $1.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CERS's P/E ratio is -11.73. In terms of profitability, AHPI's ROE is -0.68%, compared to CERS's ROE of -0.35%. Regarding short-term risk, AHPI is less volatile compared to CERS. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ZIMV has a market cap of 242.64M. Regarding current trading prices, AHPI is priced at $0.00, while ZIMV trades at $8.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ZIMV's P/E ratio is -7.07. In terms of profitability, AHPI's ROE is -0.68%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, AHPI is less volatile compared to ZIMV. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, MXCT has a market cap of 237.09M. Regarding current trading prices, AHPI is priced at $0.00, while MXCT trades at $2.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas MXCT's P/E ratio is -5.57. In terms of profitability, AHPI's ROE is -0.68%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, AHPI is less volatile compared to MXCT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, TCMD has a market cap of 224.35M. Regarding current trading prices, AHPI is priced at $0.00, while TCMD trades at $9.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas TCMD's P/E ratio is 15.08. In terms of profitability, AHPI's ROE is -0.68%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, AHPI is less volatile compared to TCMD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, NVRO has a market cap of 224.09M. Regarding current trading prices, AHPI is priced at $0.00, while NVRO trades at $5.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas NVRO's P/E ratio is -1.91. In terms of profitability, AHPI's ROE is -0.68%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, AHPI is less volatile compared to NVRO. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, EYES has a market cap of 210.05M. Regarding current trading prices, AHPI is priced at $0.00, while EYES trades at $4.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas EYES's P/E ratio is N/A. In terms of profitability, AHPI's ROE is -0.68%, compared to EYES's ROE of -0.26%. Regarding short-term risk, AHPI is less volatile compared to EYES. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BWAY has a market cap of 188.34M. Regarding current trading prices, AHPI is priced at $0.00, while BWAY trades at $9.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BWAY's P/E ratio is 55.44. In terms of profitability, AHPI's ROE is -0.68%, compared to BWAY's ROE of +0.06%. Regarding short-term risk, AHPI is less volatile compared to BWAY. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, BDMD has a market cap of 183.28M. Regarding current trading prices, AHPI is priced at $0.00, while BDMD trades at $5.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas BDMD's P/E ratio is 14.77. In terms of profitability, AHPI's ROE is -0.68%, compared to BDMD's ROE of +0.12%. Regarding short-term risk, AHPI is less volatile compared to BDMD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CATX has a market cap of 178.52M. Regarding current trading prices, AHPI is priced at $0.00, while CATX trades at $2.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CATX's P/E ratio is -2.33. In terms of profitability, AHPI's ROE is -0.68%, compared to CATX's ROE of -0.27%. Regarding short-term risk, AHPI is less volatile compared to CATX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, SGHT has a market cap of 176.82M. Regarding current trading prices, AHPI is priced at $0.00, while SGHT trades at $3.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas SGHT's P/E ratio is -3.49. In terms of profitability, AHPI's ROE is -0.68%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, AHPI is less volatile compared to SGHT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ANIK has a market cap of 175.54M. Regarding current trading prices, AHPI is priced at $0.00, while ANIK trades at $12.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ANIK's P/E ratio is -18.00. In terms of profitability, AHPI's ROE is -0.68%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, AHPI is less volatile compared to ANIK. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, QTRX has a market cap of 174.73M. Regarding current trading prices, AHPI is priced at $0.00, while QTRX trades at $4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas QTRX's P/E ratio is -3.63. In terms of profitability, AHPI's ROE is -0.68%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, AHPI is less volatile compared to QTRX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, RCEL has a market cap of 168.39M. Regarding current trading prices, AHPI is priced at $0.00, while RCEL trades at $6.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas RCEL's P/E ratio is -3.05. In terms of profitability, AHPI's ROE is -0.68%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, AHPI is less volatile compared to RCEL. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, LNSR has a market cap of 166.45M. Regarding current trading prices, AHPI is priced at $0.00, while LNSR trades at $14.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas LNSR's P/E ratio is -2.90. In terms of profitability, AHPI's ROE is -0.68%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, AHPI is less volatile compared to LNSR. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, TLSI has a market cap of 165.23M. Regarding current trading prices, AHPI is priced at $0.00, while TLSI trades at $5.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas TLSI's P/E ratio is -3.90. In terms of profitability, AHPI's ROE is -0.68%, compared to TLSI's ROE of +1.14%. Regarding short-term risk, AHPI is less volatile compared to TLSI. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ELMD has a market cap of 163.53M. Regarding current trading prices, AHPI is priced at $0.00, while ELMD trades at $19.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ELMD's P/E ratio is 26.00. In terms of profitability, AHPI's ROE is -0.68%, compared to ELMD's ROE of +0.16%. Regarding short-term risk, AHPI is less volatile compared to ELMD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, MASS has a market cap of 162.09M. Regarding current trading prices, AHPI is priced at $0.00, while MASS trades at $4.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas MASS's P/E ratio is -2.13. In terms of profitability, AHPI's ROE is -0.68%, compared to MASS's ROE of -0.13%. Regarding short-term risk, AHPI is less volatile compared to MASS. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, CVRX has a market cap of 161.39M. Regarding current trading prices, AHPI is priced at $0.00, while CVRX trades at $6.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas CVRX's P/E ratio is -2.89. In terms of profitability, AHPI's ROE is -0.68%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, AHPI is less volatile compared to CVRX. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, INGN has a market cap of 154.60M. Regarding current trading prices, AHPI is priced at $0.00, while INGN trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas INGN's P/E ratio is -5.00. In terms of profitability, AHPI's ROE is -0.68%, compared to INGN's ROE of -0.15%. Regarding short-term risk, AHPI is less volatile compared to INGN. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, AVR has a market cap of 142.68M. Regarding current trading prices, AHPI is priced at $0.00, while AVR trades at $3.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas AVR's P/E ratio is -2.01. In terms of profitability, AHPI's ROE is -0.68%, compared to AVR's ROE of -4.16%. Regarding short-term risk, AHPI is less volatile compared to AVR. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, LUNG has a market cap of 137.68M. Regarding current trading prices, AHPI is priced at $0.00, while LUNG trades at $3.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas LUNG's P/E ratio is -2.37. In terms of profitability, AHPI's ROE is -0.68%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, AHPI is less volatile compared to LUNG. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, PROF has a market cap of 136.14M. Regarding current trading prices, AHPI is priced at $0.00, while PROF trades at $4.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas PROF's P/E ratio is -3.74. In terms of profitability, AHPI's ROE is -0.68%, compared to PROF's ROE of -0.62%. Regarding short-term risk, AHPI is less volatile compared to PROF. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, RPID has a market cap of 134.13M. Regarding current trading prices, AHPI is priced at $0.00, while RPID trades at $3.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas RPID's P/E ratio is -2.83. In terms of profitability, AHPI's ROE is -0.68%, compared to RPID's ROE of -0.56%. Regarding short-term risk, AHPI is less volatile compared to RPID. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, LUCD has a market cap of 124.97M. Regarding current trading prices, AHPI is priced at $0.00, while LUCD trades at $1.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas LUCD's P/E ratio is -1.17. In terms of profitability, AHPI's ROE is -0.68%, compared to LUCD's ROE of -4.60%. Regarding short-term risk, AHPI is less volatile compared to LUCD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, MYO has a market cap of 116.21M. Regarding current trading prices, AHPI is priced at $0.00, while MYO trades at $3.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas MYO's P/E ratio is -23.07. In terms of profitability, AHPI's ROE is -0.68%, compared to MYO's ROE of -0.36%. Regarding short-term risk, AHPI is less volatile compared to MYO. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ICAD has a market cap of 107.59M. Regarding current trading prices, AHPI is priced at $0.00, while ICAD trades at $3.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ICAD's P/E ratio is -18.67. In terms of profitability, AHPI's ROE is -0.68%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, AHPI is less volatile compared to ICAD. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, HJLI has a market cap of 98.32M. Regarding current trading prices, AHPI is priced at $0.00, while HJLI trades at $10.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas HJLI's P/E ratio is N/A. In terms of profitability, AHPI's ROE is -0.68%, compared to HJLI's ROE of -0.51%. Regarding short-term risk, AHPI is less volatile compared to HJLI. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, MGRM has a market cap of 95.99M. Regarding current trading prices, AHPI is priced at $0.00, while MGRM trades at $2.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas MGRM's P/E ratio is -5.33. In terms of profitability, AHPI's ROE is -0.68%, compared to MGRM's ROE of -1.29%. Regarding short-term risk, AHPI is less volatile compared to MGRM. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, ASXC has a market cap of 94.92M. Regarding current trading prices, AHPI is priced at $0.00, while ASXC trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas ASXC's P/E ratio is -1.12. In terms of profitability, AHPI's ROE is -0.68%, compared to ASXC's ROE of -4.07%. Regarding short-term risk, AHPI is less volatile compared to ASXC. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, OWLT has a market cap of 88.41M. Regarding current trading prices, AHPI is priced at $0.00, while OWLT trades at $5.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas OWLT's P/E ratio is -3.32. In terms of profitability, AHPI's ROE is -0.68%, compared to OWLT's ROE of +1.37%. Regarding short-term risk, AHPI is less volatile compared to OWLT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.

AHPI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHPI stands at N/A. In comparison, XTNT has a market cap of 88.39M. Regarding current trading prices, AHPI is priced at $0.00, while XTNT trades at $0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHPI currently has a P/E ratio of -0.00, whereas XTNT's P/E ratio is -5.29. In terms of profitability, AHPI's ROE is -0.68%, compared to XTNT's ROE of -0.27%. Regarding short-term risk, AHPI is less volatile compared to XTNT. This indicates potentially lower risk in terms of short-term price fluctuations for AHPI.